Premium
Effect of low androgen status on the expression of adenosine A 2A and A 2B receptors in rat penile corpus cavernosum
Author(s) -
Kong XiangJun,
Jiang Jun,
Cheng Bo,
Jiang Rui
Publication year - 2019
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/and.13344
Subject(s) - medicine , endocrinology , testosterone propionate , castration , enos , androgen , androgen receptor , testosterone (patch) , adenosine receptor , adenosine , receptor , agonist , nitric oxide , nitric oxide synthase , hormone , prostate cancer , cancer
Abstract To investigate whether low androgen status affects erectile function by regulating the expression of adenosine A 2A and A 2B receptors in rat penile corpus cavernosum. Thirty‐six 8‐week‐old male Sprague‐Dawley rats were randomly divided into six groups: sham‐operated group (4w‐sham, 8w‐sham), castration group (4w‐cast, 8w‐cast) and androgen replacement group (4w‐cast+T, 8w‐cast+T). The rats in the androgen replacement groups were subcutaneously injected with testosterone propionate (3 mg/kg) every other day after castration. The maximum intracavernous pressure/mean arterial pressure (ICPmax/MAP), the expression of A 2A , A 2B , AKT and eNOS and the concentrations of cAMP and cGMP in the corpus cavernosum were detected at the 4th and 8th weeks after the operation. The serum testosterone level and the ratio of ICPmax/MAP decreased significantly in the castration group as compared to other groups ( p < 0.01). There was no significant difference in the expression of A 2A receptor among groups, while the expression of A 2B , AKT and eNOS and the concentrations of cAMP and cGMP in the castration group were significantly lower than in other groups ( p < 0.01). Low androgen status inhibits the AKT/eNOS/cGMP signalling pathways and the production of cAMP in the corpus cavernosum of castrated rats by down‐regulating the expression of A 2B receptor, and results in decreased of ICPmax/MAP.